Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Gastric Cancer

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 4 articles:
HTML format



Single Articles


    May 2023
  1. SHITARA K, Lordick F, Bang YJ, Enzinger P, et al
    Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 tr
    Lancet. 2023;401:1655-1668.
    PubMed     Abstract available


    March 2023
  2. O'MAHONY D, Power SP, Power DG
    Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab.
    Lancet. 2023;401:772.
    PubMed    


    July 2021
  3. JANJIGIAN YY, Shitara K, Moehler M, Garrido M, et al
    First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
    Lancet. 2021;398:27-40.
    PubMed     Abstract available


    January 2021

  4. Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries.
    Lancet. 2021;397:387-397.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: